Lilly posts strong early clinical results for one-shot gene-editing cholesterol therapy
A one-shot gene-editing cholesterol therapy could soon be a reality
A one-shot gene-editing cholesterol therapy could soon be a reality
AAV vectors are widely used in gene therapy for their strong therapeutic potential
The company said all doses achieved statistically significant reductions in body weight compared with placebo at 72 weeks
Highlights strong Vibegron results in older men & real-world prostate cancer insights
The new CRS offering is delivered from WACKER’s Biotechnology Center in Munich
Organizations that embrace it thoughtfully today will help shape a healthier tomorrow, for India and beyond
By leveraging digital screening and remote consultation, the medical community is moving beyond the confines of the clinic
Initiative focuses on early diagnosis, gut health awareness and long-term gluten-free care for children with celiac disease
The country’s strength lies not just in technology availability but in adoption behaviour
Subscribe To Our Newsletter & Stay Updated